Radiation therapy is the treatment of cancer and other diseases with radiation. Radiation in various forms is used to kill the cancer cells by preventing them from multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. Publisher predicts that the global radiotherapy, nuclear medicine & radiopharmaceuticals market is estimated to touch a valuation of USD 30,329 million, registering a CAGR of 9.4% during the forecast period (2022-2028). The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global radiotherapy, nuclear medicine & radiopharmaceuticals market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the radiotherapy, nuclear medicine & radiopharmaceuticals industry. This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for radiotherapy, nuclear medicine & radiopharmaceuticals can be segmented by product: radiopharmaceuticals, radiotherapy. According to the research, the radiopharmaceuticals segment had the largest share in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. Radiotherapy, nuclear medicine & radiopharmaceuticals market is further segmented by application: bone metastasis, endocrine tumor, hyperthyroidism, lymphoma, oncology, others. Based on region, the radiotherapy, nuclear medicine & radiopharmaceuticals market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). By product: - radiopharmaceuticals - radiotherapy By application: - bone metastasis - endocrine tumor - hyperthyroidism - lymphoma - oncology - others By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The radiopharmaceuticals market is further segmented into diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals. Publisher research indicates that the diagnostic radiopharmaceuticals segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the radiopharmaceuticals by production method market has been categorized into cyclotron, generator, nuclear reactor. The radiotherapy market is further divided into external beam radiation therapy, internal radiation therapy or brachytherapy, systemic radiotherapy. The report explores the recent developments and profiles of key vendors in the Global Radiotherapy, Nuclear Medicine & Radiopharmaceuticals Market, including Accuray Inc., Advanced Accelerator Applications (Novartis International AG), Australian Nuclear Science and Technology Organisation (ANSTO), Bracco S.p.A., Cardinal Health, Inc., Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, ECZACIBASI-MONROL Nuclear Products Co., Elekta AB, GE Healthcare, IBA Molecular (IBAM), IRE - IRE ELiT, Jubilant Life Sciences Ltd., Lantheus Holdings, Inc., Nordion Inc, NTP Radioisotopes SOC Ltd., Varian Medical Systems Inc., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To classify and forecast the global radiotherapy, nuclear medicine & radiopharmaceuticals market based on product, application, region. - To identify drivers and challenges for the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To identify and analyze the profile of leading players operating in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. Why Choose This Report - Gain a reliable outlook of the global radiotherapy, nuclear medicine & radiopharmaceuticals market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.